Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials
European and Developing Countries Clinical Trials Partnership
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials
Valéry Bocquet, Alphonse Ouédraogo, Alfred B. Tiono, Daouda Ouattara et al.
Journal
Malaria Journal
Topics
Malaria Research and Control
article
Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials
Valéry Bocquet, Alphonse Ouédraogo, Alfred B. Tiono, Daouda Ouattara, Michel Vaillant, Alimatou Héma, San Maurice Ouattara, Sodiomon B. Sirima, Issa Nébié, Denise Hien, Edith C. Bougouma, Emilie S. Badoum, Amidou Ouédraogo, Amidou Diarra
article en
Abstract
No abstract available for this paper.
Publication Tag
Malaria JournalVol. 23(1)
Institutions
Luxembourg Institute of Health (LU), Groupe de Recherche et d’Action sur le Foncier (BF)
Funders
European Commission, European and Developing Countries Clinical Trials Partnership